Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? : a multivalued treatment effects analysis
Year of publication: |
2024
|
---|---|
Authors: | Situ, Michael ; Schwarz, Ute I. ; Zou, Guangyong ; McArthur, Eric ; Kim, Richard B. ; Garg, Amit X. ; Sarma, Sisira |
Published in: |
The European journal of health economics. - Berlin : Springer, ISSN 1618-7601, ZDB-ID 2011428-X. - Vol. 25.2024, 3, p. 397-409
|
Subject: | Anticoagulant treatments | Atrial fibrillation | Canada | Health care costs | Multivalued treatment effect | Kanada | Gesundheitskosten | Kausalanalyse | Causality analysis |
Type of publication: | Article |
---|---|
Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
Language: | English |
Other identifiers: | 10.1007/s10198-023-01594-7 [DOI] |
Classification: | C21 - Cross-Sectional Models; Spatial Models ; C31 - Cross-Sectional Models; Spatial Models ; I10 - Health. General ; I12 - Health Production: Nutrition, Mortality, Morbidity, Substance Abuse and Addiction, Disability, and Economic Behavior ; I18 - Government Policy; Regulation; Public Health ; I19 - Health. Other |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Chapter Eight. Cost Effectiveness and Payment Policy
Garber, Alan M., (2011)
-
Houle, Christian, (2008)
-
Amiri, Arshia, (2016)
- More ...
-
The contractual arrangement for RTC of Yangtze delta
Zou, Guangyong, (2011)
-
Choice preferences on tourist resorts in Northeast China
Zou, Guangyong, (2011)
-
Interval Estimation for a Difference Between Intraclass Kappa Statistics
Dormer, Allan, (2002)
- More ...